Interferon γ-Primed Mesenchymal Stromal Cells as Prophylaxis for Acute Graft v Host Disease
Clinical trial NCT04328714 · TERMINATED
Trial details
- NCT number
- NCT04328714
- Sponsor
- Edwin Horwitz
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-02
- Primary completion
- 2022-07-20
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.